Envoy Medical, Inc. (COCH)
(Delayed Data from NSDQ)
$3.11 USD
+0.09 (2.98%)
Updated May 17, 2024 04:00 PM ET
After-Market: $3.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Envoy Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -29.91 | 19.23 | -0.25 | 0.00 | NA |
Depreciation/Amortization & Depletion | 0.13 | 0.70 | 0.50 | 0.00 | NA |
Net Change from Assets/Liabilities | -0.96 | 3.03 | 1.46 | 0.00 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 13.08 | -25.62 | -4.95 | 0.00 | NA |
Net Cash From Operating Activities | -17.65 | -2.66 | -3.24 | 0.00 | NA |
Property & Equipment | -0.15 | 0.00 | 0.00 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 1.12 | -425.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -0.15 | 1.12 | -425.00 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.11 | 0.00 | 425.00 | 0.00 | NA |
Issuance (Repayment) of Debt | 10.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 1.50 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 11.74 | 0.00 | 3.37 | 0.00 | NA |
Net Cash from Financing Activities | 21.85 | 1.50 | 428.37 | 0.00 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 4.04 | -0.04 | 0.12 | 0.00 | NA |
Cash at Beginning of Period | 0.18 | 0.15 | 0.03 | 0.00 | NA |
Cash at End of Period | 4.22 | 0.11 | 0.15 | 0.00 | NA |
Diluted Net EPS | -2.38 | 0.36 | -0.01 | NA | NA |
Fiscal Year End for Envoy Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -29.91 | -25.03 | -0.42 | 0.72 |
Depreciation/Amortization & Depletion | NA | 0.13 | 0.09 | 0.51 | 0.23 |
Net Change from Assets/Liabilities | NA | -0.96 | 5.83 | 0.19 | 0.92 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 13.08 | 13.17 | -3.13 | -4.05 |
Net Cash From Operating Activities | NA | -17.65 | -5.95 | -2.86 | -2.18 |
Property & Equipment | NA | -0.15 | -0.13 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 387.61 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 1.69 | 389.05 |
Net Cash from Investing Activities | NA | -0.15 | -0.13 | 389.30 | 389.05 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.11 | 1.00 | -387.61 | -387.61 |
Issuance (Repayment) of Debt | NA | 10.00 | 10.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 11.74 | 11.74 | 1.19 | 0.73 |
Net Cash from Financing Activities | NA | 21.85 | 22.74 | -386.42 | -386.87 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 4.04 | 16.66 | 0.03 | 0.00 |
Cash at Beginning of Period | NA | 0.18 | 0.18 | 0.11 | 0.11 |
Cash at End of Period | NA | 4.22 | 16.84 | 0.13 | 0.10 |
Diluted Net EPS | NA | -2.45 | 0.13 | -0.08 | 0.02 |